Selvita SA (SLV):企業の財務・戦略的SWOT分析

◆英語タイトル:Selvita SA (SLV) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH248860FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ポーランド
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥64,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥97,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Selvita SA (Selvita) is a clinical stage biopharmaceutical company that develops small molecule therapies for the treatment of cancer. It is evaluating its pipeline candidates including SEL120, a selective CDK8 kinase inhibitor for the treatment of hematological malignancies and solid tumors; and SEL24/MEN1703, a dual PIM/FLT3 kinase inhibitor for the treatment of acute myeloid leukemia. Selvita is also investigating various pre-clinical immuno-oncology candidates and candidates based on synthetic lethality for the treatment of solid tumors. The company has collaborations with Lund University, Jagiellonian University, Cancer Center and Institute of Oncology, and Institute of Hematology and Blood Transfusion (IHT). Selvita is headquartered in Krakow, Lesser Poland, Poland.

Selvita SA Key Recent Developments

Mar 30,2021: Breakthrough year in the development of Selvita – strategic acquisition & strong financial results
Feb 09,2021: Selvita develops the cell-based phenotypic assay platform for drug discovery
Nov 19,2020: 19/11/20 Ryvu Therapeutics Reports Q3 2020 Financial Results Read more
Sep 10,2020: Selvita reports strong financial results for H1 2020 and a record backlog

This comprehensive SWOT profile of Selvita SA provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Selvita SA including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Selvita SA – Key Information
Selvita SA – Overview
Selvita SA – Key Employees
Selvita SA – Key Employee Biographies
Selvita SA – Key Operational Heads
Selvita SA – Major Products and Services
Selvita SA – History
Selvita SA – Company Statement
Selvita SA – Locations And Subsidiaries
Selvita SA
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Selvita SA – Business Description
Selvita SA – Corporate Strategy
Selvita SA – SWOT Analysis
SWOT Analysis – Overview
Selvita SA – Strengths
Selvita SA – Weaknesses
Selvita SA – Opportunities
Selvita SA – Threats
Selvita SA – Key Competitors

Section 3 – Company Financial Performance Charts

Selvita SA – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Selvita SA, Key Information
Selvita SA, Key Ratios
Selvita SA, Share Data
Selvita SA, Major Products and Services
Selvita SA, History
Selvita SA, Key Employees
Selvita SA, Key Employee Biographies
Selvita SA, Key Operational Heads
Selvita SA, Other Locations
Selvita SA, Subsidiaries
Selvita SA, Key Competitors
Selvita SA, SWOT Analysis
Selvita SA, Ratios based on current share price
Selvita SA, Annual Ratios
Selvita SA, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Selvita SA (SLV):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pousadas de Portugal:企業の戦略・SWOT・財務情報
    Pousadas de Portugal - Strategy, SWOT and Corporate Finance Report Summary Pousadas de Portugal - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Singulex Inc-製薬・医療分野:企業M&A・提携分析
    Summary Singulex Inc (Singulex) is a medical device company develops single molecule counting technology. The company provides Sgx clarity system, an in vitro diagnostics platform that provides high sensitivity next generation immunodiagnostics. Its proprietary SMC technology allows scientists and p …
  • OWC Pharmaceutical Research Corp (OWCP):製薬・医療:M&Aディール及び事業提携情報
    Summary OWC Pharmaceutical Research Corp (OWC Pharmaceutical), formerly Dynamic Applications Corp, is a drug development company that discovers, develops, and commercializes cannabis-based novel therapeutics products and treatments for several medical conditions. The company offers sublingual solubl …
  • AGL Energy Limited:企業の戦略・SWOT・財務情報
    AGL Energy Limited - Strategy, SWOT and Corporate Finance Report Summary AGL Energy Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Ariste Medical LLC:医療機器:M&Aディール及び事業提携情報
    Summary Ariste Medical LLC (Ariste) is a medical device company that develops drug eluting surgical implants. The company develops drug eluting tunneled dialysis catheter for hemodialysis, drug eluting mesh for hernia repair, and drug eluting vascular graft for peripheral bypass. It also develops dr …
  • Phillips 66 (PSX):企業の財務・戦略的SWOT分析
    Phillips 66 (PSX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Sun BioPharma Inc (SNBP):企業の財務・戦略的SWOT分析
    Summary Sun BioPharma Inc (Sun BioPharma), formerly Cimarron Medical Inc is a biopharmaceutical company that develops disruptive therapeutics for treatment of pancreatic cancer and pancreatitis. The company’s pipeline products include SBP-101, SBP-102 and SBP-103. Its SBP-101 produces superior anti- …
  • Allianz Global Assistance SAS:企業の戦略・SWOT・財務情報
    Allianz Global Assistance SAS - Strategy, SWOT and Corporate Finance Report Summary Allianz Global Assistance SAS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Impax Laboratories Inc (IPXL)-製薬・医療分野:企業M&A・提携分析
    Summary Impax Laboratories Inc (Impax) develops, manufactures and markets generic and branded pharmaceuticals. It offers solid dose and alternative dosage form generic drugs in a broad range of therapeutic areas; and proprietary branded pharmaceutical products for the treatment of central nervous sy …
  • Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329):製薬・医療:M&Aディール及び事業提携情報
    Summary Tianjin Zhongxin Pharmaceutical Group Corp Ltd (TZPG) is engaged in the manufacturing of traditional Chinese medicine, western medicine and health products. The company offers Chinese patent medicines, Chinese medicinal materials, chemical medicines, dietary supplements, pharmaceutical raw m …
  • HDFC Bank Ltd:企業の戦略・SWOT・財務情報
    HDFC Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary HDFC Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Summit Midstream Partners LP (SMLP):石油・ガス:M&Aディール及び事業提携情報
    Summary Summit Midstream Partners LP (SMLP) is an oil and gas company that develops, owns and operates midstream energy infrastructure assets located in unconventional shale resource basins and shale formations across North America. The company operates natural gas, crude oil, and produced water gat …
  • Alabama Municipal Electric Authority:企業の戦略的SWOT分析
    Alabama Municipal Electric Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • ACell Inc:企業の製品パイプライン分析
    Summary ACell Inc (ACell) is a medical device company that offers products for wounds and various surgical procedures. The company develops and manufactures products to facilitate the body’s ability to repair and remodel tissue. Its products portfolio includes burn matrix products, multilayer wound …
  • Centra Industries, Inc.:企業の戦略・SWOT・財務情報
    Centra Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary Centra Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • VentriPoint Diagnostics Ltd-医療機器分野:企業M&A・提携分析
    Summary VentriPoint Diagnostics Ltd (Ventripoint) is a medical device company that manufactures and distributes diagnostic tools and monitoring devices for patients with heart diseases. The company offers ventripoint diagnostic system, which is a cardiovascular monitoring and measurement device. Its …
  • Neovasc Inc (NVCN):医療機器:M&Aディール及び事業提携情報
    Summary Neovasc Inc (Neovasc) is a medical device manufacturing company that manufactures, develops, and sells cardiovascular disease products. The company’s products include Neovasc reducer, Neovasc tiara, and Neovasc tissue products. Its Neovasc tiara is a novel transcatheter device that is design …
  • Waterloo Industries Inc:企業の戦略的SWOT分析
    Waterloo Industries Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • CIMB Group Holdings Berhad:企業のM&A・事業提携・投資動向
    CIMB Group Holdings Berhad - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CIMB Group Holdings Berhad Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • ReproCELL Inc (4978):製薬・医療:M&Aディール及び事業提携情報
    Summary ReproCELL Inc (ReproCELL) is a biotechnology company that develops and commercializes stem cell technologies. The company offers products in divisions such as research reagents, cultivation materials, and cell and biorepository. Its research reagent products include hES iPSC culture reagents …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆